Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Okay. Good afternoon. I'm Eric Joseph, senior biotech analyst with JPMorgan. And our next presenting company is Rocket Pharmaceuticals. It's my pleasure to welcome and introduce CEO, Gaurav Shah, to take us through the story. There will be a Q&A in the room after the presentation. There will be mics circulating. And also feel free to submit any questions via the web portal for folks that are tuning in online. Okay, with that...
Thanks, Eric. Thanks to JPMorgan for having us this year. Happy New Year. So let's start with this, how many folks in the room or who are listening online know somebody or know of somebody with a rare disease. The thing is that each rare disease may be rare, but rare disease is not rare. And I think 2023 is going to be a transformative year for gene therapy in rare disease and for Rocket Pharma.
There's 3 things that we'll focus on today. One is our clinical pipeline is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
